AusBiotech, Anna Lavelle,: AusBiotech wraps up a year of delivery for the industry




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: AusBiotech, Anna Lavelle,: AusBiotech wraps up a year of delivery for the industry
Released on: January 09, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this interview with Anna Lavelle, CEO, AusBiotech, filmed in Brisbane during the 2013 Convention Fintan Walton hears how this year has proven to be another solid period for the Australian biotechnology industry and for AusBiotech.
  • Summary
  • Transcript
  • Participants
  • Company
In this interview with Anna Lavelle, CEO, AusBiotech, filmed in Brisbane during the 2013 Convention Fintan Walton hears how this year has proven to be another solid period for the Australian biotechnology industry and for AusBiotech. Anna explains how during this time, AusBiotech was steadfast in its advocacy and active in its representation and support of the industry.
In this interview with Anna Lavelle, CEO, AusBiotech, filmed in Brisbane during the 2013 Convention Fintan Walton hears how this year has proven to be another solid period for the Australian biotechnology industry and for AusBiotech. Anna explains how during this time, AusBiotech was steadfast in its advocacy and active in its representation and support of the industry.
Anna Lavelle
AusBiotech
AusBiotech
AusBiotech is Australia's biotechnology industry organisation, which represents over 3,000 members, covering the human health, agricultural, medical device, bioinformatics, environmental and industrial sectors in biotechnology. AusBiotech is dedicated to the development, growth and prosperity of the Australian biotechnology industry, by providing initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for members nationally and around the world. AusBiotech has representation in each Australian state providing a national network to support members and promote the commercialisation of Australian bioscience in the national and international marketplaces. The structure is a not-for-profit limited guarantee company managed by a Board elected by members in line with its constitution. Click here to view the constitution. Our membership base includes biotechnology companies, ranging from start-ups to mature multinationals, research institutes and universities, specialist service professionals, corporate, institutional, individual and student members from Australia and overseas. In assessing the current needs and issues faced by Australia's core biotechnology companies, AusBiotech's Strategic Business Plan addresses the requirements to build a favourable environment to enable companies to grow, help them globalise and position Australia as a significant biotechnology industry for increasing international investment and interest.